Celltrion | 068270 - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
Avita Medical AUD 28.02M 1.55M 2025-12
Celltrion KRW 140.68B 584.31B 2025-12
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Ionis Pharmaceuticals USD 364M 54M 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
Moderna USD 1.78B 242M 2026-03
Organon & Co USD 903M 387M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Tectonic Therapeutic USD 21.52M 374K 2025-12
Viatris USD 3.54B 323.9M 2026-03
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12